Non‐interventional, prospective, observational study on spasticity‐associated symptom control with nabiximols as add‐on therapy in patients with multiple sclerosis spasticity in Austria

Abstract Background and purpose Randomized controlled trials and observational studies of nabiximols oromucosal spray in patients with multiple sclerosis (MS) spasticity have shown improvement in a range of associated symptoms (pain, spasms, fatigue, bladder dysfunction, and sleep disturbances). Thi...

Full description

Bibliographic Details
Main Authors: Michael Guger, Robert Hatschenberger, Fritz Leutmezer
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:Brain and Behavior
Subjects:
Online Access:https://doi.org/10.1002/brb3.2947